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BACKGROUND: Retrotransposons, such as LINE-1 (L1) and Alu elements, comprise 18 
more than 25% of the human genome. Their ability to retrotranspose throughout the 19 
genome is normally suppressed by epigenetic mechanisms. However, this repression 20 
is frequently lost in solid tumours through internal and external stimuli, and 21 
consequently somatic retrotransposition can be an initiating event in carcinogenesis. 22 
The epigenome in chronic lymphocytic leukaemia (CLL) is shaped by the maturation 23 
stage of the cell of origin, and its evolution during disease progression is correlated 24 
with the acquisition of genetic abnormalities associated with poor patient prognosis. 25 
Early work has demonstrated that L1 and Alu hypomethylation are associated with the 26 
acquisition of 17p deletions in CLL, but to date there has been no comprehensive or 27 
locus-specific analysis of retrotransposon DNA methylation. 28 
 29 
AIMS: To develop an approach to enable locus-specific analysis of L1 and Alu 30 
subfamily DNA methylation using the Illumina Infinium 450K microarray platform 31 
(H450K) and apply this to study aberrant methylation of L1 and Alu elements in CLL. 32 
 33 
METHODS: H450K probes mapping to retrotransposons were identified using 34 
RepeatMasker. The probeset was applied to a publicly-available dataset from a study 35 
of 138 CLL patients and 13 healthy individuals available from the International Cancer 36 
Genome Consortium. Leading hits were further analysed in Gene Expression 37 
Omnibus (GEO) datasets from 1,169 healthy individuals, 764 acute lymphoblastic 38 
leukaemia (ALL) patients, 174 acute myeloid leukaemia (AML) patients, and 31 diffuse 39 
large B-cell and Burkitt’s lymphoma patients, and also prospective samples from 82 40 
future CLL cases (<18 years from diagnosis) and 82 age-matched controls within the 41 
Melbourne Collaborative Cohort Study. 42 
 43 
RESULTS: We identified 9,549 probes mapping to 117 L1 subfamilies, and 12,806 44 
mapping to 37 Alu subfamilies. In normal B-cells from healthy individuals, DNA 45 
methylation at these sites was routinely high (mean β: 0.75), with greater variation 46 
observed in older subfamilies (L1M and AluJ) in comparison to the youngest 47 
(L1H/L1PA and AluY), especially at CpGs within 200 bases of TSS. We identified 48 
10,782 CpG sites within L1 and Alusequences that were differentially methylated 49 
between CLL patients and healthy individuals (Pfdr<0.05), of which 55 were 50 
hypomethylated in >90% of CLL patients but never in healthy individuals. 51 
Hypomethylation of Alu elements was associated with evolutionary age, with older 52 
subfamilies (AluJ) displaying greater changes than younger ones (AluY). 53 
Hypomethylation of 17 leading hits was highly confined to CLL, never observed in 54 
healthy individuals and infrequently in ALL, AML and lymphoma. In prospective 55 
samples, methylation at each of the 17 loci, located across the genome, was highly 56 
correlated within individual patients. In contrast to diagnosed CLL patients, 57 
hypomethylation at the loci was observed in only 9 future CLL cases (11%). Notably, 58 
however, this was more commonly observed in samples taken <7 years before 59 
diagnosis (7 of 24, 29%) than in those taken more than 7 years before diagnosis (2 of 60 
58, 3%). 61 
 62 
CONCLUSIONS: We have identified locus-specific hypomethylation events of L1 and 63 
Alu elements that are highly frequent and specific to CLL, and which are present prior 64 
to diagnosis for some patients. Further work is required to establish how these 65 
epigenetic changes correspond to modulation of global DNA methylation patterns in 66 
leukaemogenesis. 67 
